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Background: Percutaneous vertebroplasty (PVP) typically involves conventional lower-viscosity cement injection via
bipedicular approach. Limited evidence is available comparing the clinical outcomes and complications in treating
osteoporotic vertebral compression fractures (OVCFs) with PVP using high-viscosity cement through unipedicular or
bipedicular approach.
Methods and design: Fifty patients with OVCFs were randomly allocated into two groups adopting unipedicular
or bipedicular PVP. The efficacy of unipedicular and bipedicular PVP was assessed by comparing operation time,
X-ray exposure time, incidence of complications, vertebral height restoration, and improvement of the visual analogue
scale (VAS), Oswestry disability index (ODI) and Short Form-36 (SF-36) General Health Survey scores.
Results: The mean operative and exposure time to X-rays in the unipedicular PVP group was less than that of the
bipedicular group (p < 0.05). No statistically significant differences were observed in the VAS score, ODI score, SF-36
score, cement leakage rate or vertebral height restoration between the two groups (p > 0.05).
Conclusion: Unipedicular and bipedicular PVP are safe and effective treatments for OVCF. Compared with bipedicular
PVP, unipedicular PVP entails a shorter surgical time and lower X-ray irradiation.
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Osteoporosis is the most common systemic disorder
worldwide, characterized by low bone mass, altered bone
microarchitecture and increased risk of fragility fracture
[1, 2]. In the European Union, an estimated 22 million
women and 5.5 million men are afflicted with osteopor-
osis, with an annual cost of fractures related to osteopor-
osis pegged at euro 37.0 billion, expected to increase by
25 % in 2025 [3]. The most common fragility fractures
associated with osteoporosis are vertebral compression
fractures (OVCFs), affecting 25 % of postmenopausal
women and more than 200 million individuals* Correspondence: 17374769@qq.com
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creativecommons.org/publicdomain/zero/1.0/worldwide [4]. OVCFs cause substantial pain and de-
formity, leading to disability and poor quality of life. The
usual treatment of OVCF includes analgesics, external
braces and physical therapy. However, a few patients may
still complain of severe pain after conservative treatments
and even show progressive collapse of the vertebral body
and kyphosis with or without neurological deficit [5–7].
Various techniques of vertebral body augmentation have
been developed in an effort to treat these refractory cases.
Over the past few decades, percutaneous vertebroplasty
(PVP) has gained popularity as the optimal treatment mo-
dality for OVCF. PVP provided rapid pain relief and long-
lasting effects in a large case series and nonrandomized
controlled trails [6, 8, 9]. Although relatively safe and ef-
fective, PVP is associated with complications including ce-
ment leakage, soft tissue damage, pedicle fracture, nerve
injury and spinal epidural hematoma [10, 11].ticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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x-ray to 82 % using computed tomography (CT) [12]. While
most leakages are asymptomatic, serious complications of
nerve root or spinal cord compression and pulmonary
embolism cannot be ruled out [10, 11, 13]. Reducing ce-
ment leakage using vertebral venography, gel-foam
embolization, and kyphoplasty resulted in inconclusive
outcomes [8, 14, 15]. High-viscosity cements have been
demonstrated to effectively reduce the risk of epidural and
venous cement leakage, thereby improving overall clinical
safety [16–19]. The standard technique is typically carried
out using a bipedicular approach [18, 19]. In recent years,
unipedicular PVP has been advocated, reducing the oper-
ating and radiation exposure time, lowering the risk of ce-
ment leakage and complications caused by vertebral
pedicle puncture. In addition, it increased the cost-
effectiveness of the procedure as well as clinical efficacy.
To compare the efficacy and adverse effects of unipedicu-
lar PVP with that of bipedicular PVP using high-viscosity
cement, we conducted a prospective randomized and con-
trolled study in our hospital. To the best of our know-
ledge, there has been no such report published until now.
Methods
Patients and controls
The Institutional Review Board of our hospital (Clinical
Hospital of Yangzhou University Institutional Review
Board Committee) approved this study, and patients
provided informed consent prior to the study. From
November 2010 to October 2012, a total of 58 patients
with OVCF adopting PVP with high-viscosity bone ce-
ment were included in our study. Clinical indications
for vertebral augmentation were regularly confirmed by
an interdisciplinary team of oncologists, radiation on-
cologists, spine surgeons, and interventional radiolo-
gists prior to the intervention.
Study inclusion criteria were as follows: (1) age over
50 years; (2) single-level OVCF; (3) focal back pain in
the midline unresponsive to at least 8 weeks of conser-
vative treatments; (4) back pain related to the location of
the OVCF on magnetic resonance imaging (MRI) radio-
graphs; (5) presence of an apparent bone edema in the
fractured vertebra on T2-weighted short-tau inversion
recovery sequences (STIR) in MRI; (6) bilateral pedicle
intact without fracture; and (7) decreased bone mineral
density (T scores < −1). We excluded patients with (1)
vertebral compression fracture due to causes other than
osteoporosis; (2) spinal cord compression or stenosis of
the vertebral canal > 30 % of the local canal diameter; (3)
neurologic deficits; (4) incurable bleeding disorders; (5)
systemic or local spine infections; (6) severe comorbidity
of heart, liver, kidney, and lung intolerance to surgery.
All eligible patients were assigned a serial number ac-
cording to the consecutive sequence of hospitalizationand allocated to group U (using unipedicular approach)
or group B (using bipedicular approach) randomly by
computer. The study population consisted of 24 patients in
group U (8 male and 16 female, mean age = 69.2 years,
range = 52–81 years) and 26 patients in the group B (10
male and 16 female, mean age = 70.5 years, range = 57–83
years). All procedures were performed by the same surgeon.
Surgical technique
All surgical procedures were conducted under general
anesthesia, with the patient in prone position on a carbon-
fiber radiolucent, C-arm table. After localizing the frac-
tured vertebra using fluoroscopy, the surgeon placed
overlapping palm on the vertebral spinous process to
push ventrally slowly and partially reduce the fractured
vertebra. A small skin puncture was made approximately
2.5 cm off of mid-line. The introducer was directed to the
junction of the middle and anterior 1/3 of the affected ver-
tebral body under C-arm fluoroscopic guidance. Once the
needle was in the optimal position, the high-viscosity poly-
methylmethacrylate (PMMA) bone cement was injected
with a specially designed delivery system (Disc-O-Tech
Medical Technologies Ltd. Herzliya, Israel) according to
the manufacturer’s specifications. The injection procedure
was carefully controlled under strict lateral fluoroscopy
and stopped whenever epidural or paravertebral opacifica-
tion was observed or the cement reached the dorsal quar-
ter of the vertebral body.
Outcome measurements
We emphasized both surgical complications and clinical
outcomes in both groups three days and two years after
surgery. Outcome measures included: (1) surgery time
(from skin incision to suturing), exposure time to the X-ray
C-arm machine and cement dosage; (2) Visual Analog Scale
(VAS) score for analgesic efficacy evaluation; (3) Oswestry
Disability Index (ODI) for functional assessment; (4) Short
Form-36 General Health Survey (SF-36) for quality of life
evaluation: Physical Component Summary (PCS) and the
Mental Component Summary (MCS); (5) complications in-
cluding cement leakage and adjacent vertebral fractures;
and (6) radiographic outcomes including anterior and mid-
dle vertebral body height variation, (calculated by fractured
vertebral body height/normal vertebral body height ×
100 %). Normal heights of the vertebrae were defined as the
mean of the equivalent values for the adjacent superior and
inferior non-fractured vertebrae. Anterior and middle verte-
bral height was defined as the distance between the upper
and lower endplates at the anterior and middle vertebral
body wall and in the center of the vertebral body.
Statistical analysis
Data were presented as the mean ± standard deviation. The
SPSS for Windows Version 13.0 (SPSS, Chicago, IL) was
Table 2 Clinical outcomes of the two groups
Time Parameter Group U Group B p-value
N = 24 N = 26
Preoperative VAS 8.1 ± 1.0 8.0 ± 1.2 0.78
ODI 45.2 ± 5.1 43.2 ± 4.1 0.13
PCS 31.6 ± 4.9 29.1 ± 3.7 0.13
MCS 31.2 ± 3.9 32.1 ± 3.1 0.41
Three days VAS 2.6 ± 0.8* 2.5 ± 0.9† 0.73
postoperative
ODI 27.3 ± 4.2* 26.1 ± 3.4† 0.28
PCS 44.8 ± 5.2* 42.6 ± 4.5† 0.11
MCS 41.0 ± 3.8* 40.1 ± 4.2† 0.43
Two years VAS 2.1 ± 0.9* 2.1 ± 0.7† 0.97
postoperative
ODI 19.9 ± 4.6* 18.9 ± 2.6† 0.26
PCS 52.9 ± 3.7* 52.8 ± 5.5† 0.93
MCS 45.7 ± 3.8* 45.3 ± 3.7† 0.74
Group U: PVP through unipedicular approach
Group B: PVP through bipedicular approach
VAS visual analogue scale; ODI oswestry disability index;
PCS physical component summary; MCS mental component summary
P values for between-group comparison were determined by t tests
*P = 0.000, compared to Preoperative outcomes in Group U
†P = 0.000, compared to Preoperative outcomes in Group B
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an independent statistician blinded to the surgical proce-
dures. The statistical significance of pre- and post-surgical
clinical and radiographic data within each group and be-
tween groups was evaluated using independent t-test and
chi-square test. The difference of cement leakage between
two groups was assessed using the χ2 test. The level of stat-
istical significance was set at p <0.05.
Results
Surgical parameters
The mean surgery time was 41.2 ± 5.2 min in group U,
which was shorter than 55.7 ± 7.3 min in group B (p <
0.001) (Table 1). Patients were exposed to X-rays 33.7 ±
5.2 min in group U and 46.5 ± 6.6 min in group B, and
the difference was statistically significant (p < 0.001)
(Table 1). The bone cement volume was 3.1 ± 0.4 mL in
group U and 5.0 ± 0.5 mL in group B, and this difference
was also statistically significant (p < 0.001) (Table 1).
Clinical outcomes
There was no difference between the 2 groups in terms
of the pre-operative VAS, ODI, PCS and MCS measure-
ments (Table 2). Patients in both groups exhibited
marked and sustained pain reduction, function and qual-
ity of life improvement. Significant statistical differences
were found before and after operation in terms of VAS, ODI
and SF-36 scores (Table 2). However, no statistical differ-
ences were found 3 days or 2 years postoperatively between
the 2 groups in terms of the clinical outcomes (Table 2).
Radiological outcomes
There were no surgical complications in either group.
The bone cement leakage rate was 20.8 % (5 of 24) in
the group U and 34.6 % (9 in 26) in group B, which was
not a statistically significant difference (p = 0.28). Of the
5 bone cement leakages in group U, one occurred into
the anterior vertebra, 2 were leakages into the disc and
another 2 were venous leaks. Of the 9 bone cementTable 1 Surgical parameters of the studied population
Group U Group B p-value
N = 24 N = 26
Male/female 5:19 8:18 0.42a
Age (years) 71.7 ± 7.5 72.1 ± 6.0 0.84b
Operative time 41.2 ± 5.2 55.7 ± 7.3 0.001b
Exposed to X-rays time 33.7 ± 5.2 46.5 ± 6.6 0.001b*
Injected cement volume 3.1 ± 0.4 5.0 ± 0.5 0.001b*
Cement leakage 5 9 0.28a
Group U: PVP through unipedicular approach
Group B: PVP through bipedicular approach
aPvalues for between-group comparison were determined by χ2 tests
bPvalues for between-group comparison were determined by t tests
*Statistically significant (p value <0.05)leakages in group B, 3 occurred into the disc, one into
paravertebral, 2 into epidural, and another 3 were venous
leaks. However, no clinical symptoms were identified due
to leakage and no special treatment was necessary.
The anterior and middle vertebral heights of the fractured
vertebra before surgery showed no significant diffeence be-
tween the 2 groups (Table 3). Similarly, no statistical differ-
ence was found 3 days later or even after 2 years. However,
significant statistical differences were found before and after
the operation in terms of the anterior and middle vertebral
heights of the fractured vertebra (Table 3).
Discussion
PVP is the optimal treatment for OVCF and provides
rapid pain relief and stabilization of the fractured verte-
bral bodies [8, 20, 21]. Although cement leakage is re-
ported as high as 73 % for both PVP types, most
leakages remain clinically asymptomatic, and even small
quantities of leakage may have a significant clinical im-
pact [12]. The three factors that may influence the ce-
ment flow into and out of the vertebral body include:
bone and fracture-related parameters, cement properties,
and injection methods. Although fracture morphology is
impossible to control, the cement properties and method
of injection may be manipulated to ultimately decrease
the complication rate.
Viscosity of bone cement used in PVP is hypothesized
to influence the outcome of the procedure in various
Table 3 Radiological outcomes of the two groups
Time Parameter Group U Group B p-value
N = 24 N = 26
Preoperative Anterior vertebral body 41.8 ± 7.5 42.9 ± 8.0 0.63
height variation, %
Middle vertebral body 46.9 ± 5.4 47.3 ± 6.1 0.81
height variation, %
Three days Anterior vertebral body 56.3 ± 6.4* 59.0 ± 5.2† 0.11
postoperative height variation, %
Middle vertebral body 58.5 ± 4.8* 59.6 ± 5.5† 0.44
height variation, %
Two years Anterior vertebral body 53.0 ± 5.9* 55.6 ± 5.3† 0.11
postoperative height variation, %
Middle vertebral body 55.4 ± 5.0* 56.8 ± 5.4† 0.34
height variation, %
Group U: PVP through unipedicular approach
Group B: PVP through bipedicular approach
P values for between-group comparison were determined by t tests
*P = 0.000, compared to Preoperative outcomes in Group U
†P = 0.000, compared to Preoperative outcomes in Group B
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the cement cloud and decreased spreading distance [22,
23]. PVP with high-viscosity cement offers all the advan-
tages, especially minimizing the risk of cement leakage
and significantly increasing the clinical safety [22, 24]. In
the PVP procedure, unipedicular approach is being in-
creasingly used to treat OVCF, to reduce medical costs
and X-ray exposure, as well as for better clinical efficacy
[25, 26]. In our prospective, randomized study, both uni-
pedicular and bipedicular PVP group achieved satisfac-
tory results and patients’clinical outcome parameters
were significantly improved and consistent compared to
pre-surgical levels. The improvement in the clinical out-
come and recovery of vertebral heights were not signifi-
cantly different between the two groups under the strict
inclusion criteria.
In theory, bipedicular PVP shows increased incidence
of complications such as tissue trauma, nerve injury and
pedicle fractures. However, in our study, no pedicle frac-
tures or nerve damage occurred in either group. The
complications resulting largely from poor operative tech-
nique can be minimized at the operator level.
Some clinical studies have positively correlated the
bone cement injection volume with the leakage of bone
cement [27]. In theory, the risk of bone cement leakage
is also twice that of unipedicular approach. However the
difference in cement leakage rates between unipedicular
and bipedicular PVP with conventional viscosity cement
was not statistically significant [28–31]. The cementleakages in PVP with high-viscosity cement are still un-
known. A larger volume of injected cement through the
bipedicular approach is also more likely to result in ex-
travasations. The most common cement leakage was
venous leakage (6.1 %) and intradiscal leakage (8.2 %) in
PVP with high-viscosity Confidence bone cement re-
ported by Anselmetti et al. [22]. However, the leakage
rate was almost as high as 47 % reported by Georgy et al.
[18]. The cement leakage rates in the above two studies
were far different. By comparison, we found that the big-
gest difference may be the methods adopted (unipedicu-
lar approach by Anselmetti vs. bipedicular approach by
Georgy) and cement leakages detected (CT by Anselmetti
vs. plain film by Georgy). CT is now regarded as the
gold standard to assess cement leakage [12]. Whether
the lower cement leakage rate reported by Anselmetti
was due to the different PVP is unclear. In this study,
the cement leakage rates of both groups were lower but
not statistically significant compared with PVP using
standard low-viscosity cement. The results suggested
that increased bone cement injection did not result in
increased bone cement leakage rate, which may be at-
tributed to the nature of high-viscosity bone cement
itself.
The X-ray exposure and operation time of unipedicu-
lar approach were significantly reduced. Unipedicular
PVP lessens the radiation dose, thereby reducing health
risks to the medical staff performing the PVP. If 5 % of
all vertebral compression fractures in the United States
were treated by unipedicular kyphoplasty, instead of
bipedicular kyphoplasty, the savings would be > $32
million per year [32]. Thus, our results support the con-
cept that the unipedicular technique is a faster, cost-
effective alternative that still provides a comparable
correction of spinal deformity to the bipedicular tech-
nique. The unipedicular technique is specifically indi-
cated for the elderly, or patients who have more than
one affected vertebra.
The limitations of our study are related to the rela-
tively small sample size and the follow-up of only three
days and two years. We also failed to perform a direct
comparison of vertebroplasty with kyphoplasty using
high-viscosity cement. Further study using a larger sam-
ple size and longer or more frequent follow-ups are
needed to confirm our results.
Conclusion
Unipedicular and bipedicular PVP are safe and effective
treatments for OVCF. Although the pain relief and im-
proved physical ability were comparable with either
technique, we encourage the use of the unipedicular ap-
proach as the preferred surgical technique for treatment
of OVCFs due to less operation time, limited X-ray ex-
posure, minimal cement introduction and extravasation.
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